PenderFund Capital Management’s Intersect ENT, Inc XENT Stock Holding History

PenderFund Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,900	Closed	-$172K	–	194
2022 Q1	$172K	Buy	+4,900	New	+$134K	0.04%	88

PenderFund Capital Management's XENT Position: Q2 2022 in Review

PenderFund Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 4,900 shares — an estimated $172K sold.

PenderFund Capital Management first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $172K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

PenderFund Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
PenderFund Capital Management sold 4,900 Intersect ENT, Inc shares in Q2 2022, an estimated $172K.
PenderFund Capital Management first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
PenderFund Capital Management's Intersect ENT, Inc position peaked at $172K in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on PenderFund Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.